Trokendi Xr
Migraine, Caloric Restriction, High cholesterol + 16 more
Treatment
20 Active Studies for Trokendi Xr
Treatment for
Migraine
What is Trokendi Xr
Topiramate
The Generic name of this drug
Treatment Summary
Topiramate is an anticonvulsant medication used to treat seizures and prevent migraines. It was first approved by the FDA in 1996. In 2004, it was also approved for the prevention of migraines in adults. Since 2012, it has been approved in combination with phentermine to help adults manage their weight. It has a unique chemical structure and is made up of 40% oxygen. It was created when scientists were trying to create a new diabetes drug.
Topamax
is the brand name
Trokendi Xr Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Topamax
Topiramate
1997
526
Effectiveness
How Trokendi Xr Affects Patients
Topiramate is used to prevent seizures and treat migraine symptoms by decreasing activity in the brain. It may cause dangerous side effects such as metabolic acidosis, mood changes, suicidal thoughts and attempts, and kidney stones. When taken with valproic acid, topiramate can also lead to hypothermia.
How Trokendi Xr works in the body
Seizures are caused by uncontrolled electrical activity in the brain. Topiramate works to reduce this activity in order to treat seizures and migraines. It does this by affecting GABA receptors, which normally inhibit nerve activity, and glutamate receptors, which stimulate activity. By increasing GABA activity and decreasing glutamate activity, topiramate blocks nerve signals from firing, preventing seizures and migraines. It also blocks voltage-dependent sodium channels in the brain, another way of reducing seizure activity. It is also known to affect certain carbonic anhydrase molecules, but we don't know what effect this has yet.
When to interrupt dosage
The prescribed measure of Trokendi Xr is contingent upon the diagnosed state, such as Seizures, Weight Reduction and Tonic - clonic seizures. The amount of dosage can be found in the table below, depending on the administration technique (e.g. Tablet, coated or Tablet).
Condition
Dosage
Administration
Alcoholism
, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL
, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule, extended release - Oral, Capsule, extended release, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Solution - Oral, Solution
Obesity
, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL
, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule, extended release - Oral, Capsule, extended release, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Solution - Oral, Solution
Exercise
, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL
, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule, extended release - Oral, Capsule, extended release, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Solution - Oral, Solution
Lennox Gastaut Syndrome
, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL
, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule, extended release - Oral, Capsule, extended release, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Solution - Oral, Solution
Migraine
, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL
, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule, extended release - Oral, Capsule, extended release, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Solution - Oral, Solution
Caloric Restriction
, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL
, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule, extended release - Oral, Capsule, extended release, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Solution - Oral, Solution
High cholesterol
, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL
, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule, extended release - Oral, Capsule, extended release, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Solution - Oral, Solution
Obesity
, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL
, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule, extended release - Oral, Capsule, extended release, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Solution - Oral, Solution
at least one weight-related comorbid condition
, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL
, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule, extended release - Oral, Capsule, extended release, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Solution - Oral, Solution
Migraine Disorders
, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL
, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule, extended release - Oral, Capsule, extended release, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Solution - Oral, Solution
Obesity
, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL
, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule, extended release - Oral, Capsule, extended release, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Solution - Oral, Solution
Seizures
, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL
, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule, extended release - Oral, Capsule, extended release, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Solution - Oral, Solution
Type 2 Diabetes
, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL
, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule, extended release - Oral, Capsule, extended release, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Solution - Oral, Solution
Hypertensive disease
, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL
, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule, extended release - Oral, Capsule, extended release, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Solution - Oral, Solution
Epilepsy
, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL
, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule, extended release - Oral, Capsule, extended release, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Solution - Oral, Solution
Weight Loss
, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL
, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule, extended release - Oral, Capsule, extended release, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Solution - Oral, Solution
increase in physical activity
, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL
, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule, extended release - Oral, Capsule, extended release, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Solution - Oral, Solution
Mood Disorders
, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL
, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule, extended release - Oral, Capsule, extended release, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Solution - Oral, Solution
Chronic Weight Management therapy
, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL
, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule, extended release - Oral, Capsule, extended release, Capsule, Capsule - Oral, Tablet, coated - Oral, Tablet, coated, Solution - Oral, Solution
Warnings
Trokendi Xr Contraindications
Condition
Risk Level
Notes
Acidosis
Do Not Combine
There are 20 known major drug interactions with Trokendi Xr.
Common Trokendi Xr Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be increased when combined with Topiramate.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be increased when combined with Topiramate.
Acenocoumarol
Major
The metabolism of Acenocoumarol can be increased when combined with Topiramate.
Alectinib
Major
The metabolism of Alectinib can be increased when combined with Topiramate.
Alpelisib
Major
The metabolism of Alpelisib can be increased when combined with Topiramate.
Trokendi Xr Toxicity & Overdose Risk
Rats have been found to tolerate doses of up to 1500mg/kg of topiramate. In humans, overdosing on topiramate can cause symptoms ranging from mild to severe, such as low blood pressure, extreme acidosis, abdominal pain, seizures, confusion, dizziness, depression, and more. To treat an overdose, doctors may induce vomiting, give activated charcoal, or use dialysis.
Trokendi Xr Novel Uses: Which Conditions Have a Clinical Trial Featuring Trokendi Xr?
At present, there are 313 active trials investigating the potential of Trokendi Xr to address Type 2 Diabetes, Migraine and Exercise-associated conditions.
Condition
Clinical Trials
Trial Phases
Exercise
58 Actively Recruiting
Not Applicable, Phase 2, Phase 3
Weight Loss
0 Actively Recruiting
Mood Disorders
0 Actively Recruiting
Migraine
51 Actively Recruiting
Phase 4, Not Applicable, Phase 1, Phase 3, Phase 2, Early Phase 1
Obesity
0 Actively Recruiting
Chronic Weight Management therapy
0 Actively Recruiting
Migraine Disorders
1 Actively Recruiting
Phase 3
Hypertensive disease
27 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 3
Seizures
5 Actively Recruiting
Phase 3, Phase 2, Phase 1
High cholesterol
0 Actively Recruiting
Obesity
0 Actively Recruiting
at least one weight-related comorbid condition
0 Actively Recruiting
Lennox Gastaut Syndrome
2 Actively Recruiting
Phase 1, Phase 2, Phase 4
Obesity
0 Actively Recruiting
Caloric Restriction
0 Actively Recruiting
Epilepsy
0 Actively Recruiting
Alcoholism
7 Actively Recruiting
Not Applicable, Phase 2, Phase 3
Type 2 Diabetes
162 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 3, Phase 4, Early Phase 1
increase in physical activity
0 Actively Recruiting
Trokendi Xr Reviews: What are patients saying about Trokendi Xr?
5
Patient Review
1/16/2020
Trokendi Xr for Migraine Prevention
4.7
Patient Review
11/13/2017
Trokendi Xr for Migraine Prevention
4.3
Patient Review
1/10/2018
Trokendi Xr for Essential Tremor
2.3
Patient Review
5/31/2018
Trokendi Xr for Migraine Prevention
1.7
Patient Review
11/29/2021
Trokendi Xr for Migraine Prevention
1
Patient Review
5/12/2018
Trokendi Xr for Migraine Prevention
1
Patient Review
1/10/2020
Trokendi Xr for Migraine Prevention
1
Patient Review
5/10/2021
Trokendi Xr for Migraine Prevention
1
Patient Review
9/10/2021
Trokendi Xr for Migraine Prevention
1
Patient Review
4/15/2019
Trokendi Xr for Migraine Prevention
Patient Q&A Section about trokendi xr
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does Trokendi XR make you sleepy?
"Trokendi may cause tiredness, sleepiness, drowsiness, dizziness, changes in vision, and slowed reactions. The use of alcohol with Trokendi may increase these side effects."
Answered by AI
What is Trokendi XR used for?
"Trokendi XR is a prescription medicine that is used to prevent migraines in adults and adolescents who are at least 12 years old. It is also used to treat certain types of seizures in people who are at least 6 years old."
Answered by AI
Is Trokendi XR the same as Topamax?
"Both drugs contain the same active ingredient called topiramate. Trokendi XR comes as an extended-release (long-acting) oral capsule and Topamax come as an immediate-release tablet or capsule. Trokendi XR is taken once a day, while Topamax is usually taken twice a day, in the morning and evening."
Answered by AI
Is Trokendi XR used for weight loss?
"While Trokendi XR is not approved as a weight loss medication, it is common for patients to lose weight while taking the drug, especially at higher doses. Your doctor may prescribe Trokendi XR off-label for binge eating disorder. If you have questions about Trokendi XR and weight loss, speak with your doctor."
Answered by AI